Recruiting Pulmonary Hypertension Studies in Spokane
About Pulmonary Hypertension Clinical Trials in Spokane
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 2 pulmonary hypertension clinical trials recruiting participants in Spokane, WA. These studies are seeking a combined 935 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Teva Branded Pharmaceutical Products R&D LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Spokane — FAQ
Are there pulmonary hypertension clinical trials in Spokane?
Yes, there are 2 pulmonary hypertension clinical trials currently recruiting in Spokane, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Spokane?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.
Are clinical trials in Spokane free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 2 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 13, 2026 from ClinicalTrials.gov